Option Care Health, Inc.
NMS: OPCHLive Quote
📈 ZcoreAI Score
Our AI model analyzes Option Care Health, Inc.'s price action across multiple timeframes using regression channels and statistical scoring.
Get OPCH Z-Score →About Option Care Health, Inc.
Healthcare
Medical Care Facilities
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapy and services; home infusion services to treat heart failure; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as Duchenne muscular dystrophy, multiple sclerosis, Alzheimer's disease, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. The company markets its services through patient referrals, including physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations. The company is headquartered in Bannockburn, Illinois.
📊 Fundamental Analysis
Option Care Health, Inc. demonstrates a profit margin of 3.7%, which is below the sector average, suggesting competitive pressure.
The company recently reported 8.8% revenue growth, which is above average for the Healthcare sector.
Return on Equity (ROE) is 15.2%, which suggests room for improvement in capital utilization.
At a current price of $29.00, OPCH currently sits at the 38th percentile of its 52-week range (Range: $24.24 - $36.80).
💰 Valuation Insight
OPCH is valued broadly in line with the sector at a PE of 22.83. Analysts expect earnings growth, as indicated by a lower forward PE.
🏥 Financial Health
🔴
Profit Margin
Weak
🔴
Debt/Equity
Elevated
⚠️
Revenue Growth
Moderate
🔴
Return on Equity
Weak
⚠️
Beta (Risk)
Moderate Volatility
Key Financials
Market Cap
$4.55B
Trailing P/E
22.83
Forward P/E
13.64
Beta (5Y)
0.95
52W High
$36.80
52W Low
$24.24
Avg Volume
1.79M
Day High
Day Low